Nice one. This confirms why Calimmune called the
first drug 'Cal-1', because they have a 'Cal-2' on its
way, with the latter being the pure play shRNA approach
someone from Calimmune mentioned last year.
So yes H, yet more clinical trials using Blt ip on the way
from the other side, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)